Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas Review uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Sarcoma
  • Soft Tissue Neoplasms

abstract

  • Fixed-dose-rate gemcitabine and docetaxel is a reasonable treatment option for patients with advanced soft-tissue sarcoma. The regimen is a good choice as first-line or second-line therapy for advanced uterine leiomyosarcoma. The role of adjuvant gemcitabine-docetaxel in completely resected, uterine-limited, high-grade leiomyosarcoma is under investigation.

publication date

  • July 2010

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/CCO.0b013e32833aafef

PubMed ID

  • 20520541

Additional Document Info

start page

  • 356

end page

  • 61

volume

  • 22

number

  • 4